Institute for Tropical Technology, Vietnam Academy of Science and Technology, 18 Hoang Quoc Viet, Cau Giay, Hanoi 100000, Vietnam Graduate University of Science and Technology, Vietnam Academy of ...

Therefore, biological therapies may offer new ways of treating SLE. As a consequence, experimental use of biologics targeting B-cell activity has escalated during the past decade, in particular ...

cyclophosphamide and rituximab (Rituxan, Genentech). According to the researchers, the greatest impact on skin disease, assessed via modified Rodnan skin score, was observed among patients with ...

The potentiometric response of salicylate electrode based on complex of (1,8-diamino-3,6-dioxaoctane) nickel(II) was studied. The complex of 1,8-diamino-3,6-dioxaoctane nickel(II) [Ni(DADOO)] was used ...

Excitement is building around bakuchiol salicylate – or bakusylan – a new molecule that boosts the performance of bakuchiol in skin care formulations. The bakuchiol trend is poised to evolve.

– The Itovebi (inavolisib)-based regimen reduced the risk of death by more than 30% in people with PIK3CA-mutated HR-positive, HER2-negative advanced breast cancer, compared with palbociclib and ...

These are applied over painful joints and have fewer side effects than oral pain relievers. A few topical RA treatment options include salicylates, NSAIDs, lidocaine, menthol/camphor, capsaicin, and ...

versus Rituxan ® (rituximab) in combination with GemOx in patients with relapsed or refractory diffuse large B-cell lymphoma who have received at least one prior line of therapy and who are not ...

Pelabresib and Rituxan combination showed significant clinical benefits in JAK inhibitor-naive myelofibrosis patients, achieving a 65.9% spleen volume reduction at 24 weeks. The MANIFEST-2 trial ...

The C3 inhibitor was given pre- and post-RP-A501 treatment in combination with the enhanced prophylactic immunosuppressive regimen of sirolimus, rituximab (marketed as Rituxan® by Genentech ...